(Q35754084)

10 August 2017

1 reference

title

Isoprostanes: novel bioactive products of lipid peroxidation (English)

1 reference

10 August 2017

Samar Basu

1

1 reference

10 August 2017

1 February 2004

1 reference

10 August 2017

Free Radical Research

1 reference

10 August 2017

38

1 reference

10 August 2017

105-122

1 reference

10 August 2017

2

1 reference

Peroxy radical cyclization as a model for prostaglandin biosynthesis

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

The isoprostanes: their quantification as an index of oxidant stress status in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Delta13-reductase dependent metabolism of prostaglandins in the mammalian brain and eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

The measurement of free radical reactions in humans. Some thoughts for future experimentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Urinary isoprostane excretion is not confounded by the lipid content of the diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Critical role of lipid peroxidation in carbon tetrachloride-induced loss of aminopyrine demethylase, cytochrome P-450 and glucose 6-phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Radioimmunological measurement of F(2)-isoprostanes after hydrolysis of lipids in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

IPF2alpha-I: an index of lipid peroxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Bronchopulmonary effects of 8-epi-PGF2A in anaesthetised guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Alcohol-induced generation of lipid peroxidation products in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Greater oxidative stress in healthy young men compared with premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Association between oxidative stress and bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

No evidence for lipid peroxidation in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased formation of F(2)-isoprostanes in patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Oxidative stress and antioxidant status in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Oxygen-derived free radicals in postischemic tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Biomarkers of free radical injury during spinal cord ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Extracellular superoxide dismutase deficiency and atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Effects of vitamin E on lipid peroxidation in healthy persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Oxidative stress and platelet activation in homozygous homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Formation of isoprostanes in children with type IIa hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased exhaled 8-isoprostane in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Urinary F2-isoprostanes formation in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

Increased F2Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760310001646895

10.1080/10715760310001646895

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15104204